The PIAS1 epigenetic pathway is increased in breast cancer and, in addition to silencing genes such as ESR1, also silences the tumor suppressor WNT5A, which has been shown to increase self-renewal of breast tumor initiating cells and requires PIAS1 activity as a SUMO E3 ligase [158]. This evidence concerns the gene ESR1 and breast carcinoma.